Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection

Completed

• Conditions: Emergencies

• Registration Number: NCT04371328
• Lead Sponsor: University Hospital, Toulouse

Brief Summary

This research aims to improve knowledge of the epidemiology of patients consulting in the COvid Possible REspiratory Units (RECOP unit). Indeed, the epidemic linked to COVID19 affects France and impacts its health system. The reception of all intermediate patients will be on the Emergency Structures (SU). Indeed, the French healthcare system centralizes unscheduled urgent care on the ER. The aspecific respiratory symptomatology in "intermediate" patients indicates them all the more at an admission to SU or the diagnostic approach to respiratory difficulty may be carried out. It will be necessary to identify the diagnosis of the dyspneic patient and to define his virological status COVID before referring him to the appropriate units.

The investigatory propose an original strategy of dedicating entire care sectors to the care of patients admitted for dyspnea in our ER. These units will be named RECOP units.

This study would improve epidemiological knowledge of COVID-19 and ability to receive these patients within the SU.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-03-13
• Study First Submitted: 2020-04-29
• Study First Submitted QC: 2020-04-29
• Study First Posted: 2020-05-01
• Primary Completion: 2020-06-05
• Study Completion: 2020-06-30
• Status Verified: 2021-10
• Last Update Submitted: 2021-10-06
• Last Update Posted: 2021-10-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1860

Inclusion Criteria

• All patients over the age of 15 admitted to the RECOP unit for dyspnea

Exclusion Criteria

• Patient admitted to shock for respiratory distress requiring immediate respiratory support.
• Patient under justice safeguard

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Describe the characteristics of patients admitted to reCOP units according to their virological status vis-à-vis COVID-19	30 days	The virological condition will be taken with PCR tests on naso-pharyngeal samples or on sputum for patients taking

Secondary Outcome Measures

Name	Time	Method
Develop a predictive model of the risk of being COVID for patients admitted to the emergency room for dyspnea	0 days	demographic variables, usual history and treatments, episode characteristics (symptomatology, evolution, treatment taken) and data from the initial clinical examination will be collected by doctor

Trial Locations

Locations (1)

University Hospital of Toulouse; 🇫🇷 Toulouse, France